What they were paid
Context Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $49,558 | $0 | $67,359 | $83,332 | $200,249 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Context Therapeutics Inc. DEF 14A filed April 28, 2026, accession 0001628280-26-027928, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Context Therapeutics pays directors a $40,000 cash retainer and $120,000 in Options.
Committees
FY2025 · as the proxy prints themCompensation
The rest of the Context Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andy Pasternak | Independent Director | $159,027 |
| Jennifer Evans Stacey, Esq | Independent Director | $122,635 |
| Linda West | Independent Director | $127,359 |
| Luke Walker, MD | Independent Director | $111,135 |
| Martin Lehr | Director | $0 |
| Philip Kantoff, MD | Independent Director | $111,135 |
The full Context Therapeutics compensation record
free company briefThis page is one director within Context Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat